USS Investment Management Ltd Acquires 2,420 Shares of Waters Corporation $WAT

USS Investment Management Ltd boosted its holdings in shares of Waters Corporation (NYSE:WAT) by 12.0% during the 1st quarter, Holdings Channel.com reports. The fund owned 22,657 shares of the medical instruments supplier’s stock after purchasing an additional 2,420 shares during the period. USS Investment Management Ltd’s holdings in Waters were worth $6,749,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in WAT. IFM Investors Pty Ltd increased its stake in shares of Waters by 67.1% during the 1st quarter. IFM Investors Pty Ltd now owns 18,883 shares of the medical instruments supplier’s stock worth $5,623,000 after purchasing an additional 7,581 shares during the last quarter. Rexford Capital Inc. acquired a new stake in shares of Waters in the 1st quarter valued at $41,000. Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in Waters by 27.4% in the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 1,642 shares of the medical instruments supplier’s stock worth $489,000 after purchasing an additional 353 shares in the last quarter. Bayban bought a new stake in Waters in the first quarter worth $44,000. Finally, iA Global Asset Management Inc. increased its position in Waters by 23.1% during the first quarter. iA Global Asset Management Inc. now owns 1,740 shares of the medical instruments supplier’s stock worth $518,000 after buying an additional 326 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on WAT shares. Wolfe Research assumed coverage on Waters in a report on Tuesday, June 2nd. They set an “outperform” rating and a $425.00 target price on the stock. Evercore upgraded Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price target for the company in a research note on Monday, April 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research note on Monday, April 20th. HSBC boosted their target price on Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Finally, Barclays upped their target price on Waters from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Four research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $396.68.

Waters Stock Up 0.1%

Waters stock opened at $378.62 on Friday. The firm has a market cap of $37.18 billion, a price-to-earnings ratio of 48.11, a P/E/G ratio of 2.29 and a beta of 1.20. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $414.15. The firm has a fifty day moving average price of $350.65 and a two-hundred day moving average price of $346.80.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.39. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm’s revenue was up 91.4% compared to the same quarter last year. During the same period last year, the business posted $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, analysts forecast that Waters Corporation will post 14.51 earnings per share for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.